Skip to main content
. Author manuscript; available in PMC: 2019 Dec 6.
Published in final edited form as: Br J Haematol. 2019 Feb 6;185(6):1021–1042. doi: 10.1111/bjh.15764

Fig 4.

Fig 4.

Reduce the burden of oncological therapy (REBOOT) Group B treatment schema. COM, cyclophosphamide (cytoxan), vincristine, methotrexate; COM3RA25D1, cyclophosphamide, vincristine, methotrexate, rituximab, doxorubicin (adriamycin), dexamethasone; COP, cyclophosphamide, vincristine, prednisone; dz, disease; HC, hydrocortisone; IT, intrathecal; MTX, methotrexate; R-CyM, rituximab, cytarabine, methotrexate.